4-(Cyclohexanecarbonyl)-1-phenethyl-3,4-dihydropyrazin-2(1H)-one, with the CAS number 94494-35-6, is a chemical compound characterized by its unique structural features, including a dihydropyrazinone core and a cyclohexanecarbonyl group. This compound typically exhibits a solid state at room temperature and may have moderate solubility in organic solvents, depending on the specific functional groups present. The presence of the cyclohexanecarbonyl moiety suggests potential for interactions with biological systems, making it of interest in medicinal chemistry. Its dihydropyrazinone structure may contribute to various chemical reactivity patterns, including potential for tautomerization and participation in hydrogen bonding. Additionally, the phenethyl group can influence the compound's lipophilicity and overall pharmacokinetic properties. While specific biological activities or applications may vary, compounds of this type are often explored for their potential therapeutic effects, particularly in the fields of neuropharmacology and anti-inflammatory research. Further studies would be necessary to elucidate its complete profile, including stability, reactivity, and biological interactions.

4-(cyclohexanecarbonyl)-1-phenethyl-3,4-dihydropyrazin-2(1H)-one

94494-35-6: 4-(Cyclohexanecarbonyl)-1-phenethyl-3,4-dihydropyrazin-2(1H)-one, with the CAS number 94494-35-6, is a chemical compound characterized by its unique structural features, including a dihydropyrazinone core and a cyclohexanecarbonyl group. This compound typically exhibits a solid state at room temperature and may have moderate solubility in organic solvents, depending on the specific functional groups present. The presence of the cyclohexanecarbonyl moiety suggests potential for interactions with biological systems, making it of interest in medicinal chemistry. Its dihydropyrazinone structure may contribute to various chemical reactivity patterns, including potential for tautomerization and participation in hydrogen bonding. Additionally, the phenethyl group can influence the compound's lipophilicity and overall pharmacokinetic properties. While specific biological activities or applications may vary, compounds of this type are often explored for their potential therapeutic effects, particularly in the fields of neuropharmacology and anti-inflammatory research. Further studies would be necessary to elucidate its complete profile, including stability, reactivity, and biological interactions.

CAS 94494-35-6

4-(cyclohexanecarbonyl)-1-phenethyl-3,4-dihydropyrazin-2(1H)-one

Praziquantel Impurity 3

Ref: ST-EA-CP-P53015